康恩贝：关于子公司TFA003片获得药物临床试验批准通知书的公告

Group 1 - The core point of the article is that Kang En Bei announced the approval of its subsidiary's clinical trial for TFA003 tablets by the National Medical Products Administration [2] Group 2 - Kang En Bei's wholly-owned subsidiary, Hangzhou Kang En Bei Pharmaceutical Co., Ltd., received the clinical trial approval notice for TFA003 tablets [2]